Management of atrial fibrillation and flutter. A reappraisal of digitalis therapy.
D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000503:physiopathology; D001282:Atrial Flutter / Q000188:drug therapy* / Q000503:physiopathology; D001283:Atrioventricular Node / Q000503:physiopathology; D004071:Digitalis Glycosides / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D004077:Digoxin / Q000009:adverse effects / Q000097:blood; D004347:Drug Interactions; D004562:Electrocardiography; D004594:Electrophysiology; D006801:Humans; D007700:Kinetics; D009200:Myocardial Contraction / Q000187:drug effects; D005082:Physical Exertion; D013997:Time Factors
D004071:Digitalis Glycosides; D004077:Digoxin